García-Ortega YE, Bravo-Ruiz OL, Mireles-Ramírez MA, Ramírez-Márquez JJ, Cabrera-Gaytán DA

Language: Spanish
References: 14
Page: 795-801
PDF size: 512.48 Kb.

ABSTRACT

Creutzfeldt-Jakob disease is a neuroselective and neurodegenerative illness, with fatal course, which is rare and represents a challenge for clinical diagnosis. This paper reports the case of a 52-year-old male with a history of ingestion of wild mammals during his life, with a picture of diminished visual acuity, rapidly progressive dementia, myoclonus, abnormal movements and motor dysfunction; with auxiliary studies of differential diagnosis within normal parameters and the determination of reactive TAU protein.

REFERENCES

1. Reyes MT, Aguilar S, Corona R, Vega I, Montalvo Colón C. Enfermedad de Creutzfeldt-Jakob: Reporte de un caso y revisión de la literatura. Médica Sur 9(2);2002:79-87.

2. Calderón-Garcidueñas AL, Sagastegui-Rodríguez JA, Canales- Ibarra C, Farías-García R. Un caso de Creutzfeldt-Jakob en el noreste de México y revisión de conceptos actuales sobre enfermedad por priones. Gac Méd Méx 2001;137(6):589-594.

3. Brandel JP, Delasnerie-Lauprëtre N, Laplanche JL, Hauw JJ, Alpérovith A. Diagnosis of Creutzfeldt-Jakob disease. Effect of clinical criteria on incidence estimates. Neurology 2000;54(5). DOI: 10.1212/wnl.54.5.1095.

4. Blumenkron D, Guerrero P, Ramiro M. Enfermedad de Creutzfeldt-Jakob. Med Int Mex 2007;23:34-46.

5. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ, Bernoulli C, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence end the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-188. DOI: 10.1002/ ana.410050212.

6. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009;132(10):2659-68. doi: 10.1093/brain/awp191.

7. Otto M, Wiltfang J, Cepek L, et al. Tau protein and 14- 3-3 protein in the differential diagnosis of Creutzfeldt- Jakob disease. Neurology 2002;58:192-7. DOI: 10.1212/ wnl.58.2.192.

8. McGuire LI, Peden AH, Orrú CD, Wilham JM, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2012;72:278. doi: 10.1002/ana.23589.

9. Bongianni M, Orrú C, Groveman BR, et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurology 2017;74(2):155-62. doi: 10.1001/jamaneurol.2016.4614.

10. Manix M, Kalakoti P, Thakur J, Menger R, et al. Creutzfeldt- Jakob disease: Updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015 Nov;39(5):E2. doi: 10.3171/2015.8.FOCUS15328.

11. Madhusudhan K S, Das CJ. Creutzfeldt-Jakob disease: Importance of early magnetic resonance imaging. Ann Indian Acad Neurol 2009;12:52-3. doi: 10.4103/0972- 2327.48859.

12. Swerdlow AJ, Higgins CD, Adlard P. Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 2003;61(6):783-91. DOI: 10.1212/01.wnl.0000084000.27403.15.

13. Nuñez Cuerda L, Matías Salce ML, Colas Rubio J, Martín Barranco MJ, Marcos Sánchez F. Enfermedad de Creutzfeldt- Jakob: dos nuevos casos en Talavera de la Reina. Rev Clin Esp 2008;208:193-6. https://doi.org/10.1157/13117041.

14. Biswas A, Khandelwal N, Pandit A, Roy A, Guin DS, Gangopadhyay G, Senapati A. Case series of probable sporadic Creutzfeldt-Jakob disease from Eastern India. Ann Indian Acad Neurol 2013;16:659-63. doi: 10.4103/0972- 2327.120486.